SEC Form 4 · accession 0001645627-18-000030
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 29, 2018
Accepted (ET)
May 30, 2018 · 8:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 29, 2018 | P | 1,000 | $0.0398 | A | 25,125,989 | D | |
| Common Stock | May 29, 2018 | P | 1,000 | $0.037 | A | 25,126,989 | D | |
| Common Stock | May 29, 2018 | P | 100 | $0.037 | A | 25,127,089 | D | |
| Common Stock | May 29, 2018 | P | 1,000 | $0.037 | A | 25,128,089 | D | |
| Common Stock | May 29, 2018 | P | 1,000 | $0.0387 | A | 25,129,089 | D | |
| Common Stock | May 29, 2018 | P | 1,000 | $0.0387 | A | 25,130,089 | D |
Table II — derivative securities
No Table II lines on this filing.